The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Drug discovery is an inventive process of Medication discovered by biological target which involves the interaction of various disciplines leading to the invention of potent drug entities. The drug is most activates and inhibits the function of a biomolecule which in turn results in a therapeutic benefit to the patient. The process involves various branches of pharmacology coalesce with biotechnology, bioinformatics, molecular biology, nanotechnology and biochemistry that ultimately leads to the production of molecules of therapeutic value. The global market for drug discovery technologies has reached nearly $39.5 billion in 2013 and $46.5 billion in 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019. Developing a new drug is a tedious & expensive undertaking, despite promising discoveries and multibillion-dollar investments for new drug development is quietly undergoing crisis. Currently, all existing therapies together hit only about 400 different drug targets.
- Track 1-1Drug Target Discovery
- Track 1-2Molecular Biology - A New Route to Drug Discovery
- Track 1-3Insilco Drug Discovery
- Track 1-4Advanced Trends in Medicinal Chemistry in Drug Discovery and Designing
- Track 1-5Innovative Drug Discovery and Nanotechnology
Advanced drug delivery systems (DDS) involves inarguable advantages for drug administration.Over the past three decades, new proposals have been recommended for the evolution of novel carriers for drug delivery. General concepts and emerging research in this field based on multidisciplinary proposals aimed at generate customized treatment for a broad range of highly universality diseases (e.g., cancer and diabetes). This review is made of two parts. The first part supply an overview on currently available drug delivery technologies counting a brief history on the development of these systems and some of the research strategies applied. The second part supply information about the most advanced drug delivery devices sing stimuli-responsive polymers.
- Track 2-1Nano based drug delivery system
- Track 2-2Lipid Nanoparticle Drug Delivery System
- Track 2-3Liposomes -ocular drug delivery
- Track 2-4Hydrogel based drug delivery systems
- Track 2-5Electrospun and Electrosprayed
'Targeted drug delivery system is a special form of drug delivery system where the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs or tissues or cells.' Targeted drug delivery systems have been developed to optimize regenerative techniques. The system is based on a method that delivers a certain amount of a therapeutic agent for a prolonged period of time to a targeted diseased area within the body. This helps maintain the required plasma and tissue drug levels in the body, thereby preventing any damage to the healthy tissue via the drug. The drug delivery system is highly integrated and requires various disciplines, such as chemists, biologists, and engineers, to join forces to optimize this system.
- Track 3-1Tumor Targeting Drug Delivery
- Track 3-2Drug Delivery Vehicles
- Track 3-3Passive &Active targeting
- Track 3-4Various targeted site & receptors in the body
Anticancer agents are typically administered to the patients to kill cancer cells. These drugs work in two ways: by killing the cancer cells through direct exposure to the chemical agent and by inducing apoptosis (suicide of cancer cells). Current treatment strategies for cancer suffer from severe limitations, including nonspecific biodistribution of the chemotherapeutic agent, dose-limiting toxicity, and emerging drug resistance. As a result, novel cancer therapies such as liposomal drug delivery systems have rapidly evolved.
- Track 4-1Neural Drug Delivery
- Track 4-2Anti-Cancer Drug Discovery and Development
- Track 4-3Cancer Medicine- Bio Pharma Industry
- Track 4-4Chemotherapy
Medical devices designed for Drug delivery through the pulmonary and nasal routes. These routes are of interest for local delivery, as in asthma, but also for rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that account for specific anatomical and physiological features of the intranasal and pulmonary routes will be featured. Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are used as part of one or more medical treatments. Many in the industry have long felt overly burdened by what they consider to be an unnecessarily complex approval process. Critics claim it impedes innovation and delays the availability of better health care.
- Track 5-1Magnetic Resonance Imaging
- Track 5-2Biomedical Instrumentation Measurements
- Track 5-3Ophthalmic and ENT Instruments
- Track 5-4Ultrasonography
- Track 5-5Positron-Emission Tomographic (PET) Scanning
Therapeutic uses of a diverse of drug carrier systems have compelling effect on the treatment and possible heal of various chronic diseases, including Alzheimer, parkinsons, diabetes mellitus, cancer , psoriasis, , rheumatoid arthritis, HIV infection, infectious diseases , asthma, and drug addiction. Scientific attempts in these areas a versatile, including the biological, medical, physical, pharmaceutical, biological material, and engineering fields. Drug carrier systems are now as important as the drug itself. Controlled release supply extends delivery of a drug while sustaining its blood concentration within therapeutic limits
- Track 6-1Polymers in Drug Delivery
- Track 6-2Smart Materials for Drug Delivery
- Track 6-3Colloidal drug carriers
- Track 6-4Biomaterials in Drug Delivery
Pharmacotherapy can be characterized as the treatment and counteractive action of ailment and ailment by methods for medications of the synthetic or organic root. It positions among essential techniques for therapeutic treatment, together with surgery physical therapy, radiation, and psychotherapy. Although it is practically difficult to appraise the correct degree of the effect of pharmacotherapy on human well-being, there can be almost certain that pharmacotherapy, together with enhanced sanitation, better-eating regimen, and better lodging, has improved individuals. Phenomenal advancements in genomics and atomic science today offer a plenty of new medication targets. The utilization of present-day concoction manufactured strategies empowers the blend of many medication hopefuls in shorter circumstances than at any other time.
- Track 7-1Biopharmaceutics and drug disposition
- Track 7-2Pharmaceutical technology
- Track 7-3Pharmaceutical Microbiology & Biotechnology
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms. Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, Efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living
- Track 8-1novel transdermal drug delivery technology
- Track 8-2Magnetically Induced Drug Delivery System
- Track 8-3Phonophoresis &Iontophoresis
- Track 8-4Erythrocytes
- Track 8-5Fast dissolving tablets (FDT)
- Track 8-6Modified Drug Delivery Systems
A peptide hormone is a peptide that acts as a hormone. A proteose is a mixture of peptides produced by the hydrolysis of proteins. The term is somewhat archaic. A peptide agent (or drug) is a chemical which functions to directly modulate the peptide systems in the body or brain.Protein and Peptide drug delivery system are the Novel drug Delivery System. Proteins and peptides are the most abundant components of biological cells. They exist functioning such as enzymes, hormones, structural element and immunoglobulin.
- Track 9-1Peptide Vector for Biologics Brain Delivery
- Track 9-2Protein & peptide therapeutics
- Track 9-3Cell-penetrating and cell-targeting
- Track 9-4Oxidation and deduction
- Track 9-5Polymers for delivery of proteins
Nanotechnology and Nanoparticles in Drug Delivery. ... Perhaps the most publicized use of nanotechnology in drug delivery under development is the use of nanoparticles to deliver drugs to cancer cells. Particles are engineered so that they are attracted to diseased cells, which allows direct treatment of those cells. A method to make radiation therapy more effect in fighting prostate cancer is using radioactive gold nanoparticles attached to a molecule that is attracted to prostate Tumor cells. Researchers believe that this method will help For concentrate the radioactive nanoparticles at the cancer Tumor, allowing treatment of the Tumor with minimal damage to healthy tissue.
- Track 10-1Nano drugs, Nanomaterial & biopharmaceuticals
- Track 10-2Nanotechnology in industrial safety
- Track 10-3Nano mechanism of molecule
- Track 10-4Nanotechnology in cancer research & targeted drug delivery
- Track 10-5Bio nanotechnology & pharmaceutical engineering
Smart drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. This means of delivery is largely founded on nanomedicine which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts of the body where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of a target drug delivery system is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form.
- Track 11-1Nucleic acid drug delivery systems
- Track 11-22D and 3D printing in drug delivery
- Track 11-3Antibody targeted-drug conjugates
- Track 11-4Pulmonary drug delivery
- Track 11-5Blood brain barrier delivery
Drugdelivery to the brain is the process of passing therapeutically active molecules across the blood–brain barrier for the purpose of treating brain maladies. Drug Transport into Brain via Blood–Brain Barrier Carrier-Mediated Transporters.Gabapentin is a water-soluble drug that is active in the CNS because the drug crosses the BBB on the large neutral amino-acid transporter,72 which is LAT1.Substances cross the blood-brain barrier (BBB) by a variety of mechanisms. These include transmembrane diffusion, saturable transporters, adsorptive endocytosis, and the extracellular pathways. he blood-brain barrier is an important conduit of nutrients and cells from theblood to the brain. It also has an important function in protecting the brain from the entry of harmful substances.
- Track 12-1Development and Maturation of CNS Barriers
- Track 12-2Model Systems to Study CNS Barriers
- Track 12-3Imaging and Function of the BBB in Health and Disease
- Track 12-4Therapy and Bioherapeutic Transport Across the BBB
- Track 12-5The Gut Brain Axis and Neuroimmune Interactions
Pre-formulation& formulation aspects which is the process in which different chemical substances i.e., active chemical substances will combined together to produce a medical compound i.e., medical drug. This process involves production of drug which characterized by two things: Stability of the product, second Acceptability to the patient formulation studies focuses on factors like particle size, polymorphism, pH and solubility, in order to check whether these factors will effect on bioavailability of the drug or not. Pharmaceutical Formulations include Ophthalmic Formulation, Paediatric Formulation Development, Topical Formulation and Medication Formulation.
- Track 13-1Pre-formulation in Drug Development
- Track 13-2Product Design to Commercial Dosage Form
- Track 13-3Active Pharmaceutical Ingredients
- Track 13-4Biopharmaceutical Support in Formulation
- Track 13-5Parenteral Formulations
Herbal drug formulations means a dosage form consisting of one or more herbs or processed herbs in specified quantities to provide specific nutritional, cosmetic benefits meant for use to diagnose, treat, mitigate diseases of human beings or animals, alter the structure or physiology of human beings or animals. Herbal formulations contain an active substance or herbal substance or herbal preparation or herbal substance in combination with one or more herbal preparations. Herbal formulations are obtained by subjecting herbal substances to treatments such as extraction, distillation, expression, fractionation, purification, concentration or fermentation include Comminuted or powdered. Whole, fragmented or cut plants, plants parts, algae, fungi, lichen in an unprocessed, usually dried form but sometimes fresh were used in the preparations of herbal formulations.
- Track 14-1Chemical Constituents of Herbal Medicine
- Track 14-2Benefits of Herbal Medicine
- Track 14-3New products based on biological resources
- Track 14-4Herbs used for various biological conditions
- Track 14-5Cupping Therapies
Injectable drug delivery is considered one of the most effective routes of administration due to the speed and effectiveness of delivery to the target, as well as the improved patient experience. The global injectable drug delivery market continues to grow and technology is advancing. Oral drug delivery (ODD) is the most preferred and convenient route of drug administration due to high patient compliance, cost-effectiveness, least sterility constraints, flexibility in the design of dosage form and ease of production. From: Nanostructures for Oral Medicine
- Track 15-13d printing drugs
- Track 15-2Self-emulsifying drug delivery systems
- Track 15-3Dosage forms
- Track 15-4Future aspects of Injectable & Oral drug delivery
Pharmacovigilance is the science of collecting, monitoring, researching, assessing, and evaluating information from healthcare providers and patients on the adverse effects of the prescription medicines, over the counter medicines, vaccines and biologicals, blood products, medical devices, herbals and other traditional . Pharmacovigilance involves the collection of data on Adverse Reactions which must then be analysed and evaluated to create meaningful safety information. Signal detection in Pharmacovigilance involves looking at the adverse reaction data for patterns that suggest new safety information.
- Track 16-1Significance of Pharmacovigilance
- Track 16-2Role of pharma industries in the improvement of Pharmacovigilance system
- Track 16-3Drug Safety Updates & Solution
- Track 16-4Drug Safety Training & Surveilance
- Track 16-5Drug Safety Reporting & Monitoring
- Track 16-6Pharmacovigilance legislation
Polymers have played an integral role in the advancement of drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage release of both hydrophilic and hydrophobic drugs Polyethylene glycol (PEG) is widely utilized in drug delivery and nanotechnology due to its reported “stealth” properties and biocompatibility. It is generally thought that PEGylation allows particulate delivery systems and biomaterials to evade the immune system and thereby prolong circulation lifetimes.
- Track 17-1Micro and nano-fabrication of biodegradable polymers for drug delivery
- Track 17-2Effective drug delivery by PEGylated drug conjugates
- Track 17-3Pharmaceutical perspective
- Track 17-4Methodology
- Track 17-5Responsive polymers in controlled drug delivery
The global market for Business Development of Drug Delivery Technology in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. The U.S constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion and is expected to grow to $49 billion by 2016 at a CAGR of 5.6% in 2013, Drug Delivery Global market reached $150.3 billion, according to BCC research. This was an increase from $142 billion the previous year. Given its predicted annual growth the market represents a considerable business opportunity, which has been reflected in increasing number of drug delivery specialists. Consistent quality and competitive costs of product improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, quality control, and business development Business opportunities in drug delivery.
- Track 18-1Target Market Segment Strategy
- Track 18-2Management Summary& Personnel Plan
- Track 18-3Market Analysis Summary